A multimodal approach for diagnosing patients with acute promyelocytic leukaemia

Cytobios

Volumn 1996, Issue 350, 1996, Pages 137-149

  Mark, Hon Fong Louie ^a   Dong, Y Henry ^a   Forman, Edwin ^a   Smith, Peter ^a   Glasser, Lewis ^a  

^a NONE

Author keywords

Acute promyelocytic leukaemia; FISH; Fluorescent in situ hybridization; GTG banding

Indexed keywords

ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BONE MARROW EXAMINATION; CASE REPORT; CHROMOSOME 15; CHROMOSOME 17; CHROMOSOME BANDING PATTERN; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; GENETICS; HUMAN; MALE; MIDDLE AGED; PANCYTOPENIA; PATHOLOGY; PROMYELOCYTIC LEUKEMIA; ULTRASTRUCTURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE MARROW EXAMINATION; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 17; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; PANCYTOPENIA; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0030325303     PISSN: 00114529     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. ABUELO D., Mark H. F. L. and Bier L. 1995. Developmental delay caused by a supernumerary chromosome, inv dup (15), identified by fluorescent in situ hybridization. Clin. Pediatrics 34 223-6.
2. AFIFY A., Bland K. I. and Mark H. F .L. 1996. Fluorescent in situ hybridization assessment of chromosome copy number in breast cancer. Breast Cancer Res.Treatment 38 201-8.
3. BERGER R., Bernheim A., Daniel M-T., Valensi F. and Flandrin G. 1983. Cytological types of mitoses and chromosome abnormalities in acute leukemia. Leuk. Res. 7 221-36.
4. BRAUN L., Mikimo R., Mark H. F. L. and Lauchlan S. 1993. Establishment of biologically heterogeneous cell lines from primary cervical tumors of different histological grade. Am. J. Path. 143 832-44.
5. BULLERDIEK J., Leuschner E., Taquia E., Bonk U. and Bartnitzke S. 1993. Trisomy 8 as a recurrent clonal abnormality in breast cancer. Cancer Genet. Cytogenet. 65 64-7.
6. CHEN Z., Morgan R. and Stone J. F. 1994. Identification of complex t(15;17) in APL by FISH. Cancer Genet. Cytogenet. 72 32-74.
7. DAL CIN P., deWever I., Aerts R., Van Damme B. and Van Den Berghe H. 1991. Trisomy 8 as the only chromosome change in an epithelioid smooth muscle tumor. Gene Chrom. Cancer 3 235-7.
8. FLETCHER J. A., Naeem R., Xiao S. and Corson J. 1995. Chromosome aberrations in desmoid tumors. Trisomy 8 may be a predictor of recurrence. Cancer Genet. Cytogenet. 79 139-43.
9. GLASSER L., Fiederlein R. L., Shamdas G. J. and Brothman, A. R. 1994. Functional characteristics of in vivo induced neutrophils after differentiation therapy of acute promyelocytic leukemia with all-trans-retinoic acid. Cancer 73 1206-12.
10. GRIGNANI F., Fagioli M., Akalay M., Longo L., Pandolfi P. P., Donti E., Biondi A., Coco F. L., Grignani F. and Pelicci P. 1994. Acute promelocytic leukaemia: from genetics to treatment. (Review). Blood 83 10-25.
11. HEAD D. R., Behm F., Raimondi S., Carroll A., Slovak M., Magenis E., Willman C., Licht J., Scott A., Gresik M. V., Downing J., Butler D. and Motroni T. 1995. Genetic heterogeneity of acute myeloid leukemia (AML) with FAB-AML M3 morphology. Lab. Invest. 72 112A (abstract).
12. HEIM S. and Mitelman F. 1987. Cancer Cytogenetics. pp 73-6. Wiley-Liss, New York.
13. HEIM S. and Mitelman F. 1995. Cancer Cytogenetics. pp 96-100. Second editn. Wiley-Liss, New York.
14. LESSICK M., Israel J., Szego J., Szego K. and Wong P. 1990. Leiomyosarcoma in a patient with trisomy 8 mosaicism. J. Med. Genet. 27 643-4.
15. MANDAHL N., Heim S., Rydholm A. and Mitelman F. 1989. Non-random numerical chromosome aberrations (+8, +11, +17, +20) in infantile fibrosarcoma. Cancer Genet. Cytogenet. 40 137-8.
16. MARK H. F. L., Bayleran J. K., Seifer D. B. and Meyers-Seifer C. H. 1996. A combined cytogenetic and molecular approach for diagnosing delayed puberty. Clin. Pediat. 35 62-6.
17. MARK H. F. L. and Chow B. 1995. Localization of the gene encoding the secretin receptor on human chromosome 2q by fluorescent in situ hybridization and chromosome morphometry. Genomics 29 817-8.
18. MARK H. F. L., Grollino M. G., Sulaiman R. A. and Lathrop J. C. 1995a. Fluorescent in situ hybridization (FISH) assessment of chromosome copy number in gestational trophoblastic disease. Ann. Clin. Lab. Sci. 25 291-6.
19. MARK H. F. L., Hann E., Mikumo R., Lauchlan S., Beauregard L. and Braun L. 1995b. Cytogenetic characterization of three cell lines derived from primary cervical tumors. Ann. Clin. Lab. Sci. 25 193-207.
20. MARK H. F. L., Sikov W., Safran H., King T. C. and Griffith R. C. 1995c. Fluorescent in situ hybridization for assessing the proportion of cells with trisomy 4 in a patient with acute non-lymphoblastic leukemia. Ann. Clin. Lab. Sci. 25 330-5.
21. MARK H. F. L., Sheu M., Lopes L., Mulholland J., Takezawa K. and Sigman M. 1995d. Towards the development of a fluorescent in situ hybridization based genotoxicologic assay for aneuploidy detection in sperm. Cytobios 82 171-80.
22. MARK H. F. L., Meyers-Seifer C., Seifer D., DeMoranville B. and Jackson I. M. 1995e. Assessment of sex chromosome composition using FISH as an adjunct to GTG-banding. Ann. Clin. Lab. Sci. 25 402-8.
23. MARK H. F. L., Ahearn I. and Lathrop J. C. 1995f. Constitutional trisomy 8 mosaicism and gestational trophoblastic disease. Cancer Genet. Cytogenet. 80 150-4.
24. MARK H. F. L., Kelly T., Watson M. S., Hoeltge J., Miller W. A. and Beauregard L. 1995g. Laboratory Practices: impact of regulations on genetic testing. J. med. Gen. 32 780-6.
25. MARK H. F. L., Santoro K. and Jackson C. 1992. Characterization of chromosome 9 and 19 somatic cell and radiation hybrids: a comparison of approaches. Appl. Cytogenet. 18 149-56.
26. MARK H. F. L. 1994a Fluorescent in situ hybridization as an adjunct to conventional cytogenetics. Ann. Clin. Lab. Sci. 24 153-63.
27. MARK H. F. L. 1994b Bone marrow cytogenetics and hematologic malignancies. In The Cytogenetic Symposia, Burbank, California, pp 8-1 to 8-7. The Association of Cytogenetic Technologists.
28. MARK H. F. L. and Watson M. 1994. Evolving standards of practice for clinical cytogenetics. Rhode Island Med. 77 373-4.
29. MIRANDA R. N., Mark H. F. L. and Medeiros U. 1994. Fluorescent in situ hybridization in routinely processed bone marrow aspirate clot and core biopsy section. Am. J. Path. 145 1-6.
30. MOLENAAR W., DeJong B. and Van den Berg E. 1991. Leiomyosarcoma in a patient with trisomy 8 mosaicism. (Letters, comments). J. med. Genet. 28 724-5.
31. MOORHEAD P., Nowell P. and Mellman W. 1960. Chromosome preparation of leukocytes cultured from human peripheral blood. Expl Cell Res. 20 613-6.
32. PINKEL D., Strawne R. and Gray J. W. 1986. Cytogenetic analysis using quantitative high-sensitivity, fluorescence hybridization. Proc. natn. Acad. Sci. U.S.A. 83 2934-8.
33. POTTER A. M. and Watmore A. 1992. Malignant and acquired abnormalities. In Human Cytogenetics. Vol II, pp 27-66. Edited by D. E. Rooney and B. H. Czepulkowski. IRL Press, Oxford.
34. ROHEN C., Meyer-Bolte K., Bonk U., Ebel T., Staats B., Leuschmer E., Gohla G., Caselitz J., Bartnitzke S. and Bullerdiek J. 1995. Trisomy 8 and 18 as frequent clonal and single-cell aberrations in 185 primary breast carcinomas. Cancer Genet. Cytogenet 80 33-9.
35. ROWLEY J. D., Golomb H. M. and Dougherty C. 1977. 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet 1 549-50.
36. SCHAD C. R., Hanson C. A., Paietta E., Casper J., Jalal S. M. and Dewald G. W. 1994. Efficacy of fluorescence in situ hybridization for detecting PML/RARA gene fusion in treated and untreated acute promyelocytic leukemia. Mayo Clin. Proc. 69 1047-53.
37. SCOTT A. A., Head D. R., Kopecky K. J., Appelbaum F. R., Theil K. S., Grever M. R., Chen I. M., Whittaker M. H., Griffith B. B. and Licht J. D. 1994. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood 84 244-55.
38. SEABRIGHT M. A. 1971. A rapid banding technique for human chromosomes. Lancet 2 971-2.
39. SUMNER A. T., Evan H. J. and Buckland R. A. 1971. New technique for distinguishing between human chromosomes. Nature 232 31-2.
40. TOYOFUKA T., Mochizuki I. and Kusama S. 1987. Mediastinal germ cell tumor in trisomy 8. Eur. J. Resp. Dis. 70 245-9.